Data from A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer
E. Casado(Hospital Universitario La Paz), Paloma Cejas(Dana-Farber Cancer Institute), Rosa Miquel(Hospital Universitario La Paz), Cristóbal Belda-Iniesta(Instituto de Salud Carlos III), Joan Maurel(Breast Cancer Research Foundation), María Sereno(Hospital Universitario Infanta Sofía), Noemí Manceñido(Hospital Universitario La Paz), Benito Sánchez-Llamas(Hospital Universitario La Paz), Carlos Fernández-Martos(Fundación Instituto Valenciano de Oncología), Miguel Ángel García‐Cabezas(Boston University), Beatriz Castelo, Montserrat Blanco(Hospital Universitario La Paz), Manuel González-Barón(Hospital Universitario La Paz), José Javier Sánchez(Research Institute Hospital 12 de Octubre), Jaime Feliú(Hospital Universitario La Paz), Emilio Burgos(Hospital Universitario Infanta Sofía), Damián García‐Olmo(Hospital Universitario Fundación Jiménez Díaz)
Cited by 0
Related Papers
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
|New England Journal of Medicine|2009|2.4k
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
|The Lancet Oncology|2018|579
Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade
|Cancer Discovery|2021|286
Distinction of Neurons, Glia and Endothelial Cells in the Cerebral Cortex: An Algorithm Based on Cytological Features
|Frontiers in Neuroanatomy|2016|233